

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 7.01796248 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.01796248 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.87045444 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.63937377 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.50055232 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.34697962 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.12974042 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.28951490 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.04339038 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.78672917 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.72969729 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.72969729 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.72969729 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.72969729 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.72969729 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.72969729 |
| 17 | negative T cell selection (GO:0043383) | 4.69632327 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.68748826 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.62970005 |
| 20 | detection of other organism (GO:0098543) | 4.56679594 |
| 21 | response to interleukin-15 (GO:0070672) | 4.54200586 |
| 22 | detection of bacterium (GO:0016045) | 4.45893132 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.37721617 |
| 24 | leukocyte aggregation (GO:0070486) | 4.36736805 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.35498875 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 4.13093884 |
| 27 | positive T cell selection (GO:0043368) | 4.09172575 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.01026099 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00816463 |
| 30 | neutrophil activation involved in immune response (GO:0002283) | 3.93843028 |
| 31 | type I interferon signaling pathway (GO:0060337) | 3.91130571 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.91130571 |
| 33 | response to type I interferon (GO:0034340) | 3.90453875 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.84895285 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.84287800 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.84167785 |
| 37 | T cell selection (GO:0045058) | 3.83694391 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.79580014 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 3.78778769 |
| 40 | cellular extravasation (GO:0045123) | 3.73947031 |
| 41 | thymic T cell selection (GO:0045061) | 3.70862663 |
| 42 | T cell migration (GO:0072678) | 3.69959617 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.68122815 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.63790089 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.61333535 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.61215750 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.60288954 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58177656 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.54801518 |
| 50 | microglial cell activation (GO:0001774) | 3.51124538 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.49038997 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.46433035 |
| 53 | tolerance induction (GO:0002507) | 3.46123833 |
| 54 | detection of molecule of bacterial origin (GO:0032490) | 3.46055356 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.41471860 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39068134 |
| 57 | positive regulation of granulocyte differentiation (GO:0030854) | 3.38565315 |
| 58 | neutrophil activation (GO:0042119) | 3.36997009 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34078392 |
| 60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.33762399 |
| 61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32777572 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32717117 |
| 63 | response to host immune response (GO:0052572) | 3.32717117 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.32580041 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.32560117 |
| 66 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.28204282 |
| 67 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.28204282 |
| 68 | respiratory burst (GO:0045730) | 3.26087293 |
| 69 | positive regulation of tolerance induction (GO:0002645) | 3.22513730 |
| 70 | response to peptidoglycan (GO:0032494) | 3.19862723 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17423661 |
| 72 | negative regulation of innate immune response (GO:0045824) | 3.16695017 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16072212 |
| 74 | response to host (GO:0075136) | 3.16072212 |
| 75 | response to host defenses (GO:0052200) | 3.16072212 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 3.14031151 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09946342 |
| 78 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.09248526 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.02720293 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02118768 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02118768 |
| 82 | granulocyte activation (GO:0036230) | 2.99274804 |
| 83 | defense response to protozoan (GO:0042832) | 2.99001494 |
| 84 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98693579 |
| 85 | macrophage activation (GO:0042116) | 2.98183186 |
| 86 | dendritic cell migration (GO:0036336) | 2.97136341 |
| 87 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.96054160 |
| 88 | dendritic cell chemotaxis (GO:0002407) | 2.94592645 |
| 89 | neutrophil mediated immunity (GO:0002446) | 2.94138419 |
| 90 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.93693091 |
| 91 | * activated T cell proliferation (GO:0050798) | 2.92242236 |
| 92 | germinal center formation (GO:0002467) | 2.89912870 |
| 93 | B cell mediated immunity (GO:0019724) | 2.89728917 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.89632257 |
| 95 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.86760341 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86357420 |
| 97 | negative regulation of adaptive immune response (GO:0002820) | 2.85417519 |
| 98 | interferon-gamma production (GO:0032609) | 2.84910697 |
| 99 | positive regulation of antigen processing and presentation (GO:0002579) | 2.83299382 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83022317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.39652530 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.00851406 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.86995610 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.12189799 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.91426463 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83950892 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48063516 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.35255561 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.08754952 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98358493 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.94894543 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91921789 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.79000557 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59716750 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54149959 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.44927290 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.44555636 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38677347 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34231429 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34172742 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.32076479 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27994821 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25563923 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.22954300 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22562191 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20822266 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19920967 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15956547 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13283194 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10054193 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04059297 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 2.01080299 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.00238833 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88995276 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.77854804 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71230591 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67110607 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66151356 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66096372 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64639048 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62316883 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61611230 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57656967 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56351849 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53169316 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52740774 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51665403 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50372801 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47129865 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.43469279 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41520193 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40704953 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36333599 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34655653 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30814654 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29948979 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28323647 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26454512 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25949397 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22413872 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20585518 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.18168432 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17017918 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16796937 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16072454 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15141841 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14867986 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14364728 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13677410 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12515935 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12229644 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11522555 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10906790 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10603579 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08663221 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07984526 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07951479 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07659586 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06237918 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03503077 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01058804 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00350954 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97129650 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94530665 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93116879 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92746824 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92341849 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90319746 |
| 89 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90118970 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87957899 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86064752 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83598734 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80534130 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80401326 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77670130 |
| 96 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.77568471 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76086738 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75839041 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75138118 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71777648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.65488626 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.10346097 |
| 3 | MP0003436_decreased_susceptibility_to | 3.92234402 |
| 4 | MP0005671_abnormal_response_to | 3.43504465 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.34875539 |
| 6 | MP0001800_abnormal_humoral_immune | 3.25579809 |
| 7 | MP0003303_peritoneal_inflammation | 3.05011675 |
| 8 | MP0000685_abnormal_immune_system | 2.99997455 |
| 9 | MP0005387_immune_system_phenotype | 2.94607237 |
| 10 | MP0001790_abnormal_immune_system | 2.94607237 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.90663433 |
| 12 | MP0005025_abnormal_response_to | 2.83894870 |
| 13 | MP0002419_abnormal_innate_immunity | 2.81597957 |
| 14 | MP0009785_altered_susceptibility_to | 2.77850316 |
| 15 | MP0002723_abnormal_immune_serum | 2.72891440 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.64635047 |
| 17 | MP0001819_abnormal_immune_cell | 2.61780823 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.61739388 |
| 19 | MP0006082_CNS_inflammation | 2.50563049 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.42291890 |
| 21 | MP0002405_respiratory_system_inflammati | 2.12267136 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.12189410 |
| 23 | MP0002398_abnormal_bone_marrow | 2.11494457 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.11061362 |
| 25 | MP0000716_abnormal_immune_system | 2.04129011 |
| 26 | MP0003866_abnormal_defecation | 2.01039273 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.96764051 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.96663414 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.93108637 |
| 30 | MP0008260_abnormal_autophagy | 1.81825476 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.80782170 |
| 32 | MP0004947_skin_inflammation | 1.79854128 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.78614070 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.78605063 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.76889005 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.75202805 |
| 37 | MP0002722_abnormal_immune_system | 1.71890576 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.70361520 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.67520320 |
| 40 | MP0004381_abnormal_hair_follicle | 1.63380853 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.63165669 |
| 42 | MP0002429_abnormal_blood_cell | 1.59294540 |
| 43 | MP0001873_stomach_inflammation | 1.48917312 |
| 44 | MP0002132_abnormal_respiratory_system | 1.47126755 |
| 45 | MP0003828_pulmonary_edema | 1.42498133 |
| 46 | MP0008469_abnormal_protein_level | 1.40755854 |
| 47 | MP0004883_abnormal_blood_vessel | 1.40462886 |
| 48 | MP0001851_eye_inflammation | 1.37216047 |
| 49 | MP0005310_abnormal_salivary_gland | 1.36235395 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.34987981 |
| 51 | MP0000858_altered_metastatic_potential | 1.33751457 |
| 52 | MP0009764_decreased_sensitivity_to | 1.27640483 |
| 53 | MP0005451_abnormal_body_composition | 1.26611620 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.18279122 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.16160796 |
| 56 | MP0002933_joint_inflammation | 1.13723769 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.09130774 |
| 58 | MP0009278_abnormal_bone_marrow | 1.07825102 |
| 59 | MP0002006_tumorigenesis | 1.05687172 |
| 60 | MP0005164_abnormal_response_to | 1.03864587 |
| 61 | MP0003690_abnormal_glial_cell | 1.01223522 |
| 62 | MP0001663_abnormal_digestive_system | 0.95113529 |
| 63 | MP0005166_decreased_susceptibility_to | 0.93739054 |
| 64 | MP0003045_fibrosis | 0.93625958 |
| 65 | MP0001853_heart_inflammation | 0.91303590 |
| 66 | MP0009763_increased_sensitivity_to | 0.90552908 |
| 67 | MP0002009_preneoplasia | 0.90084391 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.88487400 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.88487400 |
| 70 | MP0003448_altered_tumor_morphology | 0.87680575 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.87230730 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.86449065 |
| 73 | MP0000604_amyloidosis | 0.86038317 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.80234071 |
| 75 | MP0000015_abnormal_ear_pigmentation | 0.78924336 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.78362105 |
| 77 | MP0005390_skeleton_phenotype | 0.76731170 |
| 78 | MP0000249_abnormal_blood_vessel | 0.76227622 |
| 79 | MP0003075_altered_response_to | 0.75542743 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.73943057 |
| 81 | MP0003091_abnormal_cell_migration | 0.71668372 |
| 82 | MP0000490_abnormal_crypts_of | 0.71055356 |
| 83 | MP0004510_myositis | 0.70334379 |
| 84 | MP0004130_abnormal_muscle_cell | 0.70255619 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.68706788 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.68048276 |
| 87 | MP0003252_abnormal_bile_duct | 0.67680626 |
| 88 | MP0001958_emphysema | 0.64876578 |
| 89 | MP0008004_abnormal_stomach_pH | 0.62657400 |
| 90 | MP0003795_abnormal_bone_structure | 0.61060894 |
| 91 | MP0008874_decreased_physiological_sensi | 0.60223956 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.56450433 |
| 93 | MP0000343_altered_response_to | 0.56417572 |
| 94 | MP0004484_altered_response_of | 0.55957679 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55305636 |
| 96 | MP0005388_respiratory_system_phenotype | 0.53140820 |
| 97 | MP0002133_abnormal_respiratory_system | 0.53140820 |
| 98 | MP0005381_digestive/alimentary_phenotyp | 0.51788347 |
| 99 | MP0000609_abnormal_liver_physiology | 0.49611080 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.48613308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.53317727 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.37753298 |
| 3 | Myositis (HP:0100614) | 5.37179485 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.29530253 |
| 5 | Orchitis (HP:0100796) | 4.86400147 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.81772884 |
| 7 | Optic neuritis (HP:0100653) | 4.70176182 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.70176182 |
| 9 | T lymphocytopenia (HP:0005403) | 4.67215257 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.47210868 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.44940447 |
| 12 | Abnormality of T cell number (HP:0011839) | 4.44021506 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.43985092 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.41377257 |
| 15 | Stomatitis (HP:0010280) | 4.38853042 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.21811339 |
| 17 | Meningitis (HP:0001287) | 3.96596789 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.90889433 |
| 19 | Recurrent skin infections (HP:0001581) | 3.83959536 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.81685800 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.81685800 |
| 22 | Encephalitis (HP:0002383) | 3.79099477 |
| 23 | Pustule (HP:0200039) | 3.68087603 |
| 24 | Vasculitis (HP:0002633) | 3.67178910 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.66065647 |
| 26 | Abnormality of T cells (HP:0002843) | 3.55739097 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.54627905 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.54171840 |
| 29 | Obstructive lung disease (HP:0006536) | 3.54171840 |
| 30 | Increased IgE level (HP:0003212) | 3.47160959 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.39172897 |
| 32 | Gingivitis (HP:0000230) | 3.39010574 |
| 33 | Recurrent viral infections (HP:0004429) | 3.32124350 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.28496690 |
| 35 | Chest pain (HP:0100749) | 3.26805452 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.22170490 |
| 37 | Keratoconjunctivitis (HP:0001096) | 3.16797697 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.14965456 |
| 39 | Leukocytosis (HP:0001974) | 3.12160472 |
| 40 | Hemoptysis (HP:0002105) | 3.06764880 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 3.03566409 |
| 42 | Recurrent bronchitis (HP:0002837) | 2.99921350 |
| 43 | Granulocytopenia (HP:0001913) | 2.96097196 |
| 44 | Gingival bleeding (HP:0000225) | 2.95860822 |
| 45 | Urticaria (HP:0001025) | 2.95833537 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.94114806 |
| 47 | Hypochromic anemia (HP:0001931) | 2.88793703 |
| 48 | Colitis (HP:0002583) | 2.86169988 |
| 49 | Cellulitis (HP:0100658) | 2.86035595 |
| 50 | Epistaxis (HP:0000421) | 2.81335247 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76720117 |
| 52 | Increased IgM level (HP:0003496) | 2.76676956 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.73774877 |
| 54 | Lymphopenia (HP:0001888) | 2.71594729 |
| 55 | Eosinophilia (HP:0001880) | 2.71282408 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.71034836 |
| 57 | Arterial thrombosis (HP:0004420) | 2.69085816 |
| 58 | Pulmonary embolism (HP:0002204) | 2.67308724 |
| 59 | Agammaglobulinemia (HP:0004432) | 2.66972861 |
| 60 | Papilledema (HP:0001085) | 2.64894364 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59686206 |
| 62 | Peritonitis (HP:0002586) | 2.57873247 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.47451198 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.42584201 |
| 65 | Chronic otitis media (HP:0000389) | 2.41382890 |
| 66 | Osteomyelitis (HP:0002754) | 2.41083209 |
| 67 | Anorexia (HP:0002039) | 2.40859090 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.39074822 |
| 69 | IgM deficiency (HP:0002850) | 2.37499791 |
| 70 | Chronic diarrhea (HP:0002028) | 2.37425212 |
| 71 | IgG deficiency (HP:0004315) | 2.35422735 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.32610562 |
| 73 | Episodic fever (HP:0001954) | 2.32608766 |
| 74 | Microcytic anemia (HP:0001935) | 2.25116603 |
| 75 | Papilloma (HP:0012740) | 2.24182019 |
| 76 | Verrucae (HP:0200043) | 2.24182019 |
| 77 | Gangrene (HP:0100758) | 2.23683406 |
| 78 | Sepsis (HP:0100806) | 2.22050655 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.21416251 |
| 80 | Viral hepatitis (HP:0006562) | 2.17678917 |
| 81 | Joint swelling (HP:0001386) | 2.13409767 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.13348310 |
| 83 | Acute hepatic failure (HP:0006554) | 2.10437614 |
| 84 | Glomerulopathy (HP:0100820) | 2.10023645 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 2.07622820 |
| 86 | Skin ulcer (HP:0200042) | 2.06934116 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.05390660 |
| 88 | Stomach cancer (HP:0012126) | 2.02597057 |
| 89 | Abnormality of the endocardium (HP:0004306) | 1.96745844 |
| 90 | Petechiae (HP:0000967) | 1.95258352 |
| 91 | Nasal polyposis (HP:0100582) | 1.93815496 |
| 92 | Amyloidosis (HP:0011034) | 1.93249812 |
| 93 | Skin rash (HP:0000988) | 1.92072847 |
| 94 | Abnormality of the fingertips (HP:0001211) | 1.89972753 |
| 95 | Keratitis (HP:0000491) | 1.89437815 |
| 96 | Recurrent sinusitis (HP:0011108) | 1.88494653 |
| 97 | Premature loss of primary teeth (HP:0006323) | 1.86914678 |
| 98 | Restrictive lung disease (HP:0002091) | 1.86607461 |
| 99 | Subacute progressive viral hepatitis (HP:0006572) | 1.86192077 |
| 100 | Purpura (HP:0000979) | 1.84535668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.23920358 |
| 2 | RIPK4 | 4.10488836 |
| 3 | TYK2 | 3.11948773 |
| 4 | BLK | 2.83349921 |
| 5 | TXK | 2.78052509 |
| 6 | FES | 2.59099360 |
| 7 | CSK | 2.50976288 |
| 8 | TAOK3 | 2.48901763 |
| 9 | PRPF4B | 2.33746903 |
| 10 | GRK6 | 2.30731301 |
| 11 | IRAK4 | 2.28234428 |
| 12 | ZAP70 | 2.22447902 |
| 13 | ERN1 | 2.19558080 |
| 14 | MAP2K3 | 2.11718700 |
| 15 | JAK3 | 2.10354538 |
| 16 | IKBKE | 2.05870465 |
| 17 | BTK | 2.02138241 |
| 18 | JAK1 | 1.99453097 |
| 19 | TNK2 | 1.96316377 |
| 20 | MAP3K14 | 1.95876902 |
| 21 | EPHB1 | 1.89859295 |
| 22 | SYK | 1.82183846 |
| 23 | MAP3K13 | 1.71438881 |
| 24 | ITK | 1.71131046 |
| 25 | HCK | 1.65528566 |
| 26 | FGFR4 | 1.51451803 |
| 27 | LCK | 1.42279834 |
| 28 | TBK1 | 1.39093274 |
| 29 | TEC | 1.37297246 |
| 30 | LYN | 1.36928391 |
| 31 | KIT | 1.36029723 |
| 32 | FGR | 1.35846674 |
| 33 | JAK2 | 1.32670163 |
| 34 | FGFR3 | 1.27770208 |
| 35 | MAP3K3 | 1.21356120 |
| 36 | CSF1R | 1.20155475 |
| 37 | SIK3 | 1.16370479 |
| 38 | MARK3 | 1.08684580 |
| 39 | NLK | 1.07723292 |
| 40 | TAOK1 | 1.06225010 |
| 41 | MAP3K1 | 1.05923589 |
| 42 | BMPR2 | 0.98053759 |
| 43 | KSR2 | 0.96605728 |
| 44 | YES1 | 0.95427727 |
| 45 | IKBKB | 0.94107895 |
| 46 | CAMKK2 | 0.91403073 |
| 47 | MARK2 | 0.91280905 |
| 48 | MAP3K11 | 0.88620732 |
| 49 | EPHA3 | 0.86863941 |
| 50 | PDK1 | 0.84927714 |
| 51 | IRAK1 | 0.84187309 |
| 52 | STK10 | 0.83264590 |
| 53 | SIK2 | 0.79611292 |
| 54 | CDC42BPA | 0.79220586 |
| 55 | PTK6 | 0.79150800 |
| 56 | MAP3K7 | 0.78744555 |
| 57 | PRKCQ | 0.77329732 |
| 58 | HIPK2 | 0.76345023 |
| 59 | TRIB3 | 0.74553724 |
| 60 | TGFBR2 | 0.72367160 |
| 61 | CAMKK1 | 0.71846293 |
| 62 | PRKD2 | 0.70899616 |
| 63 | MAP3K10 | 0.70196850 |
| 64 | MAPK7 | 0.69829181 |
| 65 | MAP3K6 | 0.69751503 |
| 66 | PTK2B | 0.68726136 |
| 67 | PIK3CG | 0.68276696 |
| 68 | MATK | 0.66394247 |
| 69 | LRRK2 | 0.66177499 |
| 70 | FYN | 0.65741155 |
| 71 | MAPK12 | 0.63932183 |
| 72 | PIM1 | 0.63090278 |
| 73 | MAP3K2 | 0.61180610 |
| 74 | PDPK1 | 0.55282653 |
| 75 | MAPK11 | 0.55237643 |
| 76 | ACVR1B | 0.54785676 |
| 77 | STK38 | 0.54234151 |
| 78 | RET | 0.53774031 |
| 79 | DYRK1B | 0.53104055 |
| 80 | SGK3 | 0.47473855 |
| 81 | STK11 | 0.44264142 |
| 82 | MAP2K6 | 0.43937853 |
| 83 | CDK4 | 0.42664487 |
| 84 | RIPK1 | 0.42204933 |
| 85 | SGK2 | 0.41093485 |
| 86 | MELK | 0.39353755 |
| 87 | TRPM7 | 0.37270517 |
| 88 | GRK7 | 0.37196274 |
| 89 | MAP3K5 | 0.36140060 |
| 90 | PRKCH | 0.35650522 |
| 91 | PDGFRB | 0.33442247 |
| 92 | RAF1 | 0.33368913 |
| 93 | MAP2K2 | 0.33274216 |
| 94 | TAOK2 | 0.33249363 |
| 95 | SMG1 | 0.32531675 |
| 96 | CDK19 | 0.31027465 |
| 97 | WNK1 | 0.30771166 |
| 98 | TYRO3 | 0.30764480 |
| 99 | IRAK2 | 0.30052630 |
| 100 | CDK6 | 0.29567976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.03164788 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88248726 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.86668994 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74646242 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.73959525 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62397199 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56100411 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.39921792 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30276221 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14489692 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.11426276 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05850316 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.99458698 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.95441868 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85469343 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82736446 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.81174649 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78771693 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77830254 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77144534 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76258965 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71648276 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63237692 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61124085 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.59988558 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57404775 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56818515 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54181904 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.53062054 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47781456 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47128330 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.47068731 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26106462 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23362754 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22559337 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.19375324 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.15257235 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14044233 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.13159309 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06246540 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.04265151 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01871269 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.00694741 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99480026 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97576607 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97367093 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.94591931 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.90218961 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88143059 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87756838 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87176978 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86871229 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85205244 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84058998 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76853412 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76841789 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74135957 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73793599 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.71983018 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71409453 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70963966 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69696489 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68601799 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65443637 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65327074 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64381670 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.63700072 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63188023 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61651834 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58984909 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57046169 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57043808 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56187643 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55965655 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55563839 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54876597 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.54634359 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.54184367 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53323612 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52867755 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51352836 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51030162 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50120571 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49264997 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45366356 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.41237895 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41230600 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38372229 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.34985812 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34863347 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.34519858 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32584796 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31626376 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31249880 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30004118 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29592927 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29024600 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27690929 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26834356 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.25586887 |

